نتائج البحث - Leli Zeng

تنقيح النتائج
  1. 1
    Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy

    Polymeric Encapsulation of a Ruthenium Polypyridine Complex for Tumor Targeted One- and Two-Photon Photodynamic Therapy حسب Johannes Karges, Jia Li, Leli Zeng, Hui Chao, Gilles Gasser

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer

    Tyrosine phosphorylation-mediated YAP1-TFAP2A interactions coordinate transcription and trastuzumab resistance in HER2+ breast cancer حسب Hailin Zou, Juan Luo, Yibo Guo, Liang Deng, Leli Zeng, Yihang Pan, Peng Li

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

    Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells حسب Leli Zeng, Yu Chen, Jiangping Liu, Huaiyi Huang, Ruilin Guan, Liang‐Nian Ji, Hui Chao

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    The development of anticancer ruthenium(<scp>ii</scp>) complexes: from single molecule compounds to nanomaterials

    The development of anticancer ruthenium(<scp>ii</scp>) complexes: from single molecule compounds to nanomaterials حسب Leli Zeng, Pranav Gupta, Yanglu Chen, Enju Wang, Liang‐Nian Ji, Hui Chao, Zhe‐Sheng Chen

    منشور في 2017
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Understanding and targeting resistance mechanisms in cancer

    Understanding and targeting resistance mechanisms in cancer حسب Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, John N.D. Wurpel, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Long non-coding RNAs regulate drug resistance in cancer

    Long non-coding RNAs regulate drug resistance in cancer حسب Kaisheng Liu, Lin Gao, Xiaoshi Ma, Juanjuan Huang, Juan Chen, Leli Zeng, Charles R. Ashby, Chang Zou, Zhe‐Sheng Chen

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications

    Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications حسب Huibin Song, Dongcheng Liu, Shaowei Dong, Leli Zeng, Zhuo‐Xun Wu, Pan Zhao, Litu Zhang, Zhe‐Sheng Chen, Chang Zou

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells

    Osimertinib (AZD9291), a Mutant-Selective EGFR Inhibitor, Reverses ABCB1-Mediated Drug Resistance in Cancer Cells حسب Xiaoyu Zhang, Yunkai Zhang, Yi‐Jun Wang, Pranav Gupta, Leli Zeng, Megan Xu, Xiuqi Wang, Dong‐Hua Yang, Zhe‐Sheng Chen

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Oncosis-inducing cyclometalated iridium(<scp>iii</scp>) complexes

    Oncosis-inducing cyclometalated iridium(<scp>iii</scp>) complexes حسب Ruilin Guan, Yu Chen, Leli Zeng, Thomas W. Rees, Chengzhi Jin, Juanjuan Huang, Zhe‐Sheng Chen, Liang‐Nian Ji, Hui Chao

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Advancements in nanoparticle-based treatment approaches for skin cancer therapy

    Advancements in nanoparticle-based treatment approaches for skin cancer therapy حسب Leli Zeng, B.H. Jaswanth Gowda, Mohammed Gulzar Ahmed, Mohammed A. S. Abourehab, Zhe‐Sheng Chen, Changhua Zhang, Jia Li, Prashant Kesharwani

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and Degradation

    DDR1 Drives Malignant Progression of Gastric Cancer by Suppressing HIF‐1α Ubiquitination and Degradation حسب Zhewei Wei, Jin Li, Li Zhong, Dongjie Yang, Wuguo Li, Wei Chen, Hao Zhou, Yulong He, Song Wu, Boyan Wang, Leli Zeng

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells حسب Wei Zhang, Yingfang Fan, Chao‐Yun Cai, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Leli Zeng, Pranav Gupta, Zhe‐Sheng Chen

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells

    Inhibition of phosphoglycerate dehydrogenase induces ferroptosis and overcomes enzalutamide resistance in castration-resistant prostate cancer cells حسب Jinxiang Wang, Leli Zeng, Nisha Wu, Yanling Liang, Jie Jin, Mingming Fan, Xiaoju Lai, Zhe‐Sheng Chen, Yihang Pan, Fangyin Zeng, Fan Deng

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Signaling pathways and therapeutic interventions in gastric cancer

    Signaling pathways and therapeutic interventions in gastric cancer حسب Zi‐Ning Lei, Qiu‐Xu Teng, Tian Qin, Wei Chen, Yuhao Xie, Kaiming Wu, Qianlin Zeng, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen, Yulong He

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis

    The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis حسب Zi‐Ning Lei, Qiu-Xu Teng, Jagadish Koya, Yangruiyu Liu, Zizhou Chen, Leli Zeng, Zhe‐Sheng Chen, Shuo Fang, Jinxiang Wang, Yuchen Liu, Yihang Pan

    منشور في 2024
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells حسب Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Leli Zeng, Yihang Pan, Dong‐Hua Yang, Zhe‐Sheng Chen

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression

    Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p/STAT6 axis to promote gastric cancer progression حسب Cuncan Deng, Mingyu Huo, Hongwu Chu, Xiaomei Zhuang, Guofei Deng, Wenchao Li, Hongfa Wei, Leli Zeng, Yulong He, Huashan Liu, Jia Li, Changhua Zhang, Hengxing Chen

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

    Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters حسب Yingfang Fan, Wei Zhang, Leli Zeng, Zi‐Ning Lei, Chao‐Yun Cai, Pranav Gupta, Dong‐Hua Yang, Qingbin Cui, Zuodong Qin, Zhe‐Sheng Chen, Louis D. Trombetta

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers

    Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers حسب Bo Li, Hui Chen, Shaohua Yang, Feng Chen, Liangliang Xu, Yan Li, Mingzhe Li, Chengming Zhu, Fangyuan Shao, Xinhua Zhang, Chu‐Xia Deng, Leli Zeng, Yulong He, Changhua Zhang

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    PUM1 Promotes Tumor Progression by Activating DEPTOR‐Meditated Glycolysis in Gastric Cancer

    PUM1 Promotes Tumor Progression by Activating DEPTOR‐Meditated Glycolysis in Gastric Cancer حسب Songcheng Yin, Huifang Liu, Zhijun Zhou, Xiaoyu Xu, Pengliang Wang, Wei Chen, Guofei Deng, Han Wang, Hong Yu, Liang Gu, Mingyu Huo, Min Li, Leli Zeng, Yulong He, Changhua Zhang

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: